Association between serum lipids and antipsychotic response in schizophrenia

firemonkey · March 2, 2019, 1:10pm

ncbi.nlm.nih.gov

Association between serum lipids and antipsychotic response in schizophrenia.

DD Kim, AM Barr, DH Fredrikson, WG Honer and RM Procyshyn, Current neuropharmacology, Feb 27 2019

Metabolic abnormalities are serious health problems in individuals with schizophrenia. Paradoxically, studies have noted an association where individuals who gained body weight or who have increases in their serum lipids demonstrated better antipsychotic response. As serum lipids serve as more specific physiological markers than body weight, the objective of this study was to review studies that examined the association between changes in serum lipids and changes in symptoms during antipsychotic treatment in individuals with schizophrenia. A Medline® literature search was performed. Fourteen studies were included and analyzed. Evidence suggests that increases in serum lipids may be associated with decreases in symptoms during antipsychotic treatment. This inverse association may be independent of confounding variables, such as weight gain, and may be most evident during treatment with clozapine. Also, according to recent randomized controlled trials, lipid-lowering agents do not appear to worsen symptoms although this needs to be further investigated in clozapine-treated patients. Future studies should investigate the association in question in a larger population and identify underlying mechanisms.

Priscillame · March 2, 2019, 4:05pm

AP’s definately mess with your metabolism, grr.

Topic		Replies	Views
Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis News	1	604	November 14, 2017
Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis News	0	175	July 1, 2020
Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia News	0	401	January 26, 2015
Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain News	1	27	February 19, 2025
Lipidomics research provides clues for drug resistance in schizophrenia News	0	273	July 6, 2021

Association between serum lipids and antipsychotic response in schizophrenia

Related topics